Mesenchymal Stem Cells Industry Research Report 2024
Summary
Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.
According to APO Research, The global Mesenchymal Stem Cells market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Mesenchymal Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Mesenchymal Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Mesenchymal Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Mesenchymal Stem Cells include Lonza, Thermo Fisher, Bio-Techne, ATCC, MilliporeSigma, PromoCell GmbH, Genlantis, Celprogen and Cell Applications, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mesenchymal Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesenchymal Stem Cells.
The Mesenchymal Stem Cells market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mesenchymal Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesenchymal Stem Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mesenchymal Stem Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesenchymal Stem Cells.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Mesenchymal Stem Cells companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.
According to APO Research, The global Mesenchymal Stem Cells market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Mesenchymal Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Mesenchymal Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Mesenchymal Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Mesenchymal Stem Cells include Lonza, Thermo Fisher, Bio-Techne, ATCC, MilliporeSigma, PromoCell GmbH, Genlantis, Celprogen and Cell Applications, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mesenchymal Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesenchymal Stem Cells.
The Mesenchymal Stem Cells market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mesenchymal Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Lonza
- Thermo Fisher
- Bio-Techne
- ATCC
- MilliporeSigma
- PromoCell GmbH
- Genlantis
- Celprogen
- Cell Applications
- Cyagen Biosciences
- Axol Bioscience
- Human MSC
- Mouse MSC
- Rat MSC
- Others
- Research Institute
- Hospital
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesenchymal Stem Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mesenchymal Stem Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesenchymal Stem Cells.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Mesenchymal Stem Cells companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Mesenchymal Stem Cells by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Human MSC
2.2.3 Mouse MSC
2.2.4 Rat MSC
2.2.5 Others
2.3 Mesenchymal Stem Cells by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Research Institute
2.3.3 Hospital
2.3.4 Others
2.4 Assumptions and Limitations
3 MESENCHYMAL STEM CELLS BREAKDOWN DATA BY TYPE
3.1 Global Mesenchymal Stem Cells Historic Market Size by Type (2019-2024)
3.2 Global Mesenchymal Stem Cells Forecasted Market Size by Type (2025-2030)
4 MESENCHYMAL STEM CELLS BREAKDOWN DATA BY APPLICATION
4.1 Global Mesenchymal Stem Cells Historic Market Size by Application (2019-2024)
4.2 Global Mesenchymal Stem Cells Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Mesenchymal Stem Cells Market Perspective (2019-2030)
5.2 Global Mesenchymal Stem Cells Growth Trends by Region
5.2.1 Global Mesenchymal Stem Cells Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Mesenchymal Stem Cells Historic Market Size by Region (2019-2024)
5.2.3 Mesenchymal Stem Cells Forecasted Market Size by Region (2025-2030)
5.3 Mesenchymal Stem Cells Market Dynamics
5.3.1 Mesenchymal Stem Cells Industry Trends
5.3.2 Mesenchymal Stem Cells Market Drivers
5.3.3 Mesenchymal Stem Cells Market Challenges
5.3.4 Mesenchymal Stem Cells Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Mesenchymal Stem Cells Players by Revenue
6.1.1 Global Top Mesenchymal Stem Cells Players by Revenue (2019-2024)
6.1.2 Global Mesenchymal Stem Cells Revenue Market Share by Players (2019-2024)
6.2 Global Mesenchymal Stem Cells Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Mesenchymal Stem Cells Head office and Area Served
6.4 Global Mesenchymal Stem Cells Players, Product Type & Application
6.5 Global Mesenchymal Stem Cells Players, Date of Enter into This Industry
6.6 Global Mesenchymal Stem Cells Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Mesenchymal Stem Cells Market Size (2019-2030)
7.2 North America Mesenchymal Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Mesenchymal Stem Cells Market Size by Country (2019-2024)
7.4 North America Mesenchymal Stem Cells Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Mesenchymal Stem Cells Market Size (2019-2030)
8.2 Europe Mesenchymal Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Mesenchymal Stem Cells Market Size by Country (2019-2024)
8.4 Europe Mesenchymal Stem Cells Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Mesenchymal Stem Cells Market Size (2019-2030)
9.2 Asia-Pacific Mesenchymal Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Mesenchymal Stem Cells Market Size by Country (2019-2024)
9.4 Asia-Pacific Mesenchymal Stem Cells Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Mesenchymal Stem Cells Market Size (2019-2030)
10.2 Latin America Mesenchymal Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Mesenchymal Stem Cells Market Size by Country (2019-2024)
10.4 Latin America Mesenchymal Stem Cells Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Mesenchymal Stem Cells Market Size (2019-2030)
11.2 Middle East & Africa Mesenchymal Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2019-2024)
11.4 Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Lonza
12.1.1 Lonza Company Information
12.1.2 Lonza Business Overview
12.1.3 Lonza Revenue in Mesenchymal Stem Cells Business (2019-2024)
12.1.4 Lonza Mesenchymal Stem Cells Product Portfolio
12.1.5 Lonza Recent Developments
12.2 Thermo Fisher
12.2.1 Thermo Fisher Company Information
12.2.2 Thermo Fisher Business Overview
12.2.3 Thermo Fisher Revenue in Mesenchymal Stem Cells Business (2019-2024)
12.2.4 Thermo Fisher Mesenchymal Stem Cells Product Portfolio
12.2.5 Thermo Fisher Recent Developments
12.3 Bio-Techne
12.3.1 Bio-Techne Company Information
12.3.2 Bio-Techne Business Overview
12.3.3 Bio-Techne Revenue in Mesenchymal Stem Cells Business (2019-2024)
12.3.4 Bio-Techne Mesenchymal Stem Cells Product Portfolio
12.3.5 Bio-Techne Recent Developments
12.4 ATCC
12.4.1 ATCC Company Information
12.4.2 ATCC Business Overview
12.4.3 ATCC Revenue in Mesenchymal Stem Cells Business (2019-2024)
12.4.4 ATCC Mesenchymal Stem Cells Product Portfolio
12.4.5 ATCC Recent Developments
12.5 MilliporeSigma
12.5.1 MilliporeSigma Company Information
12.5.2 MilliporeSigma Business Overview
12.5.3 MilliporeSigma Revenue in Mesenchymal Stem Cells Business (2019-2024)
12.5.4 MilliporeSigma Mesenchymal Stem Cells Product Portfolio
12.5.5 MilliporeSigma Recent Developments
12.6 PromoCell GmbH
12.6.1 PromoCell GmbH Company Information
12.6.2 PromoCell GmbH Business Overview
12.6.3 PromoCell GmbH Revenue in Mesenchymal Stem Cells Business (2019-2024)
12.6.4 PromoCell GmbH Mesenchymal Stem Cells Product Portfolio
12.6.5 PromoCell GmbH Recent Developments
12.7 Genlantis
12.7.1 Genlantis Company Information
12.7.2 Genlantis Business Overview
12.7.3 Genlantis Revenue in Mesenchymal Stem Cells Business (2019-2024)
12.7.4 Genlantis Mesenchymal Stem Cells Product Portfolio
12.7.5 Genlantis Recent Developments
12.8 Celprogen
12.8.1 Celprogen Company Information
12.8.2 Celprogen Business Overview
12.8.3 Celprogen Revenue in Mesenchymal Stem Cells Business (2019-2024)
12.8.4 Celprogen Mesenchymal Stem Cells Product Portfolio
12.8.5 Celprogen Recent Developments
12.9 Cell Applications
12.9.1 Cell Applications Company Information
12.9.2 Cell Applications Business Overview
12.9.3 Cell Applications Revenue in Mesenchymal Stem Cells Business (2019-2024)
12.9.4 Cell Applications Mesenchymal Stem Cells Product Portfolio
12.9.5 Cell Applications Recent Developments
12.10 Cyagen Biosciences
12.10.1 Cyagen Biosciences Company Information
12.10.2 Cyagen Biosciences Business Overview
12.10.3 Cyagen Biosciences Revenue in Mesenchymal Stem Cells Business (2019-2024)
12.10.4 Cyagen Biosciences Mesenchymal Stem Cells Product Portfolio
12.10.5 Cyagen Biosciences Recent Developments
12.11 Axol Bioscience
12.11.1 Axol Bioscience Company Information
12.11.2 Axol Bioscience Business Overview
12.11.3 Axol Bioscience Revenue in Mesenchymal Stem Cells Business (2019-2024)
12.11.4 Axol Bioscience Mesenchymal Stem Cells Product Portfolio
12.11.5 Axol Bioscience Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Mesenchymal Stem Cells by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Human MSC
2.2.3 Mouse MSC
2.2.4 Rat MSC
2.2.5 Others
2.3 Mesenchymal Stem Cells by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Research Institute
2.3.3 Hospital
2.3.4 Others
2.4 Assumptions and Limitations
3 MESENCHYMAL STEM CELLS BREAKDOWN DATA BY TYPE
3.1 Global Mesenchymal Stem Cells Historic Market Size by Type (2019-2024)
3.2 Global Mesenchymal Stem Cells Forecasted Market Size by Type (2025-2030)
4 MESENCHYMAL STEM CELLS BREAKDOWN DATA BY APPLICATION
4.1 Global Mesenchymal Stem Cells Historic Market Size by Application (2019-2024)
4.2 Global Mesenchymal Stem Cells Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Mesenchymal Stem Cells Market Perspective (2019-2030)
5.2 Global Mesenchymal Stem Cells Growth Trends by Region
5.2.1 Global Mesenchymal Stem Cells Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Mesenchymal Stem Cells Historic Market Size by Region (2019-2024)
5.2.3 Mesenchymal Stem Cells Forecasted Market Size by Region (2025-2030)
5.3 Mesenchymal Stem Cells Market Dynamics
5.3.1 Mesenchymal Stem Cells Industry Trends
5.3.2 Mesenchymal Stem Cells Market Drivers
5.3.3 Mesenchymal Stem Cells Market Challenges
5.3.4 Mesenchymal Stem Cells Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Mesenchymal Stem Cells Players by Revenue
6.1.1 Global Top Mesenchymal Stem Cells Players by Revenue (2019-2024)
6.1.2 Global Mesenchymal Stem Cells Revenue Market Share by Players (2019-2024)
6.2 Global Mesenchymal Stem Cells Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Mesenchymal Stem Cells Head office and Area Served
6.4 Global Mesenchymal Stem Cells Players, Product Type & Application
6.5 Global Mesenchymal Stem Cells Players, Date of Enter into This Industry
6.6 Global Mesenchymal Stem Cells Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Mesenchymal Stem Cells Market Size (2019-2030)
7.2 North America Mesenchymal Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Mesenchymal Stem Cells Market Size by Country (2019-2024)
7.4 North America Mesenchymal Stem Cells Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Mesenchymal Stem Cells Market Size (2019-2030)
8.2 Europe Mesenchymal Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Mesenchymal Stem Cells Market Size by Country (2019-2024)
8.4 Europe Mesenchymal Stem Cells Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Mesenchymal Stem Cells Market Size (2019-2030)
9.2 Asia-Pacific Mesenchymal Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Mesenchymal Stem Cells Market Size by Country (2019-2024)
9.4 Asia-Pacific Mesenchymal Stem Cells Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Mesenchymal Stem Cells Market Size (2019-2030)
10.2 Latin America Mesenchymal Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Mesenchymal Stem Cells Market Size by Country (2019-2024)
10.4 Latin America Mesenchymal Stem Cells Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Mesenchymal Stem Cells Market Size (2019-2030)
11.2 Middle East & Africa Mesenchymal Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2019-2024)
11.4 Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Lonza
12.1.1 Lonza Company Information
12.1.2 Lonza Business Overview
12.1.3 Lonza Revenue in Mesenchymal Stem Cells Business (2019-2024)
12.1.4 Lonza Mesenchymal Stem Cells Product Portfolio
12.1.5 Lonza Recent Developments
12.2 Thermo Fisher
12.2.1 Thermo Fisher Company Information
12.2.2 Thermo Fisher Business Overview
12.2.3 Thermo Fisher Revenue in Mesenchymal Stem Cells Business (2019-2024)
12.2.4 Thermo Fisher Mesenchymal Stem Cells Product Portfolio
12.2.5 Thermo Fisher Recent Developments
12.3 Bio-Techne
12.3.1 Bio-Techne Company Information
12.3.2 Bio-Techne Business Overview
12.3.3 Bio-Techne Revenue in Mesenchymal Stem Cells Business (2019-2024)
12.3.4 Bio-Techne Mesenchymal Stem Cells Product Portfolio
12.3.5 Bio-Techne Recent Developments
12.4 ATCC
12.4.1 ATCC Company Information
12.4.2 ATCC Business Overview
12.4.3 ATCC Revenue in Mesenchymal Stem Cells Business (2019-2024)
12.4.4 ATCC Mesenchymal Stem Cells Product Portfolio
12.4.5 ATCC Recent Developments
12.5 MilliporeSigma
12.5.1 MilliporeSigma Company Information
12.5.2 MilliporeSigma Business Overview
12.5.3 MilliporeSigma Revenue in Mesenchymal Stem Cells Business (2019-2024)
12.5.4 MilliporeSigma Mesenchymal Stem Cells Product Portfolio
12.5.5 MilliporeSigma Recent Developments
12.6 PromoCell GmbH
12.6.1 PromoCell GmbH Company Information
12.6.2 PromoCell GmbH Business Overview
12.6.3 PromoCell GmbH Revenue in Mesenchymal Stem Cells Business (2019-2024)
12.6.4 PromoCell GmbH Mesenchymal Stem Cells Product Portfolio
12.6.5 PromoCell GmbH Recent Developments
12.7 Genlantis
12.7.1 Genlantis Company Information
12.7.2 Genlantis Business Overview
12.7.3 Genlantis Revenue in Mesenchymal Stem Cells Business (2019-2024)
12.7.4 Genlantis Mesenchymal Stem Cells Product Portfolio
12.7.5 Genlantis Recent Developments
12.8 Celprogen
12.8.1 Celprogen Company Information
12.8.2 Celprogen Business Overview
12.8.3 Celprogen Revenue in Mesenchymal Stem Cells Business (2019-2024)
12.8.4 Celprogen Mesenchymal Stem Cells Product Portfolio
12.8.5 Celprogen Recent Developments
12.9 Cell Applications
12.9.1 Cell Applications Company Information
12.9.2 Cell Applications Business Overview
12.9.3 Cell Applications Revenue in Mesenchymal Stem Cells Business (2019-2024)
12.9.4 Cell Applications Mesenchymal Stem Cells Product Portfolio
12.9.5 Cell Applications Recent Developments
12.10 Cyagen Biosciences
12.10.1 Cyagen Biosciences Company Information
12.10.2 Cyagen Biosciences Business Overview
12.10.3 Cyagen Biosciences Revenue in Mesenchymal Stem Cells Business (2019-2024)
12.10.4 Cyagen Biosciences Mesenchymal Stem Cells Product Portfolio
12.10.5 Cyagen Biosciences Recent Developments
12.11 Axol Bioscience
12.11.1 Axol Bioscience Company Information
12.11.2 Axol Bioscience Business Overview
12.11.3 Axol Bioscience Revenue in Mesenchymal Stem Cells Business (2019-2024)
12.11.4 Axol Bioscience Mesenchymal Stem Cells Product Portfolio
12.11.5 Axol Bioscience Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Mesenchymal Stem Cells Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Mesenchymal Stem Cells Revenue Market Share by Type (2018-2023)
Table 7. Global Mesenchymal Stem Cells Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Mesenchymal Stem Cells Revenue Market Share by Type (2024-2029)
Table 9. Global Mesenchymal Stem Cells Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Mesenchymal Stem Cells Revenue Market Share by Application (2018-2023)
Table 11. Global Mesenchymal Stem Cells Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Mesenchymal Stem Cells Revenue Market Share by Application (2024-2029)
Table 13. Global Mesenchymal Stem Cells Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Mesenchymal Stem Cells Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Mesenchymal Stem Cells Market Share by Region (2018-2023)
Table 16. Global Mesenchymal Stem Cells Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Mesenchymal Stem Cells Market Share by Region (2024-2029)
Table 18. Mesenchymal Stem Cells Market Trends
Table 19. Mesenchymal Stem Cells Market Drivers
Table 20. Mesenchymal Stem Cells Market Challenges
Table 21. Mesenchymal Stem Cells Market Restraints
Table 22. Global Top Mesenchymal Stem Cells Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Mesenchymal Stem Cells Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Mesenchymal Stem Cells Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Mesenchymal Stem Cells, Headquarters and Area Served
Table 26. Global Mesenchymal Stem Cells Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Mesenchymal Stem Cells by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Mesenchymal Stem Cells Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Mesenchymal Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Mesenchymal Stem Cells Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Mesenchymal Stem Cells Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Mesenchymal Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Mesenchymal Stem Cells Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Mesenchymal Stem Cells Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Mesenchymal Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Mesenchymal Stem Cells Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Mesenchymal Stem Cells Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Mesenchymal Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Mesenchymal Stem Cells Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Mesenchymal Stem Cells Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2024-2029) & (US$ Million)
Table 45. Lonza Company Detail
Table 46. Lonza Business Overview
Table 47. Lonza Mesenchymal Stem Cells Product
Table 48. Lonza Revenue in Mesenchymal Stem Cells Business (2017-2022) & (US$ Million)
Table 49. Lonza Recent Development
Table 50. Thermo Fisher Company Detail
Table 51. Thermo Fisher Business Overview
Table 52. Thermo Fisher Mesenchymal Stem Cells Product
Table 53. Thermo Fisher Revenue in Mesenchymal Stem Cells Business (2017-2022) & (US$ Million)
Table 54. Thermo Fisher Recent Development
Table 55. Bio-Techne Company Detail
Table 56. Bio-Techne Business Overview
Table 57. Bio-Techne Mesenchymal Stem Cells Product
Table 58. Bio-Techne Revenue in Mesenchymal Stem Cells Business (2017-2022) & (US$ Million)
Table 59. Bio-Techne Recent Development
Table 60. ATCC Company Detail
Table 61. ATCC Business Overview
Table 62. ATCC Mesenchymal Stem Cells Product
Table 63. ATCC Revenue in Mesenchymal Stem Cells Business (2017-2022) & (US$ Million)
Table 64. ATCC Recent Development
Table 65. MilliporeSigma Company Detail
Table 66. MilliporeSigma Business Overview
Table 67. MilliporeSigma Mesenchymal Stem Cells Product
Table 68. MilliporeSigma Revenue in Mesenchymal Stem Cells Business (2017-2022) & (US$ Million)
Table 69. MilliporeSigma Recent Development
Table 70. PromoCell GmbH Company Detail
Table 71. PromoCell GmbH Business Overview
Table 72. PromoCell GmbH Mesenchymal Stem Cells Product
Table 73. PromoCell GmbH Revenue in Mesenchymal Stem Cells Business (2017-2022) & (US$ Million)
Table 74. PromoCell GmbH Recent Development
Table 75. Genlantis Company Detail
Table 76. Genlantis Business Overview
Table 77. Genlantis Mesenchymal Stem Cells Product
Table 78. Genlantis Revenue in Mesenchymal Stem Cells Business (2017-2022) & (US$ Million)
Table 79. Genlantis Recent Development
Table 80. Celprogen Company Detail
Table 81. Celprogen Business Overview
Table 82. Celprogen Mesenchymal Stem Cells Product
Table 83. Celprogen Revenue in Mesenchymal Stem Cells Business (2017-2022) & (US$ Million)
Table 84. Celprogen Recent Development
Table 85. Cell Applications Company Detail
Table 86. Cell Applications Business Overview
Table 87. Cell Applications Mesenchymal Stem Cells Product
Table 88. Cell Applications Revenue in Mesenchymal Stem Cells Business (2017-2022) & (US$ Million)
Table 89. Cell Applications Recent Development
Table 90. Cyagen Biosciences Company Detail
Table 91. Cyagen Biosciences Business Overview
Table 92. Cyagen Biosciences Mesenchymal Stem Cells Product
Table 93. Cyagen Biosciences Revenue in Mesenchymal Stem Cells Business (2017-2022) & (US$ Million)
Table 94. Cyagen Biosciences Recent Development
Table 95. Axol Bioscience Company Detail
Table 96. Axol Bioscience Business Overview
Table 97. Axol Bioscience Mesenchymal Stem CellsProduct
Table 98. Axol Bioscience Revenue in Mesenchymal Stem Cells Business (2017-2022) & (US$ Million)
Table 99. Axol Bioscience Recent Development
Table 100. Lonza Company Information
Table 101. Lonza Business Overview
Table 102. Lonza Mesenchymal Stem Cells Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million)
Table 103. Lonza Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 104. Lonza Recent Development
Table 105. Thermo Fisher Company Information
Table 106. Thermo Fisher Business Overview
Table 107. Thermo Fisher Mesenchymal Stem Cells Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million)
Table 108. Thermo Fisher Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 109. Thermo Fisher Recent Development
Table 110. Bio-Techne Company Information
Table 111. Bio-Techne Business Overview
Table 112. Bio-Techne Mesenchymal Stem Cells Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million)
Table 113. Bio-Techne Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 114. Bio-Techne Recent Development
Table 115. ATCC Company Information
Table 116. ATCC Business Overview
Table 117. ATCC Mesenchymal Stem Cells Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million)
Table 118. ATCC Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 119. ATCC Recent Development
Table 120. MilliporeSigma Company Information
Table 121. MilliporeSigma Business Overview
Table 122. MilliporeSigma Mesenchymal Stem Cells Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million)
Table 123. MilliporeSigma Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 124. MilliporeSigma Recent Development
Table 125. PromoCell GmbH Company Information
Table 126. PromoCell GmbH Business Overview
Table 127. PromoCell GmbH Mesenchymal Stem Cells Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million)
Table 128. PromoCell GmbH Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 129. PromoCell GmbH Recent Development
Table 130. Genlantis Company Information
Table 131. Genlantis Business Overview
Table 132. Genlantis Mesenchymal Stem Cells Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million)
Table 133. Genlantis Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 134. Genlantis Recent Development
Table 135. Celprogen Company Information
Table 136. Celprogen Business Overview
Table 137. Celprogen Mesenchymal Stem Cells Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million)
Table 138. Celprogen Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 139. Celprogen Recent Development
Table 140. Cell Applications Company Information
Table 141. Cell Applications Business Overview
Table 142. Cell Applications Mesenchymal Stem Cells Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million)
Table 143. Cell Applications Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 144. Cell Applications Recent Development
Table 145. Cyagen Biosciences Company Information
Table 146. Cyagen Biosciences Business Overview
Table 147. Cyagen Biosciences Mesenchymal Stem Cells Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million)
Table 148. Cyagen Biosciences Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 149. Cyagen Biosciences Recent Development
Table 150. Axol Bioscience Company Information
Table 151. Axol Bioscience Business Overview
Table 152. Axol Bioscience Mesenchymal Stem CellsRevenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million)
Table 153. Axol Bioscience Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 154. Axol Bioscience Recent Development
Table 155. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Mesenchymal Stem Cells Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Mesenchymal Stem Cells Revenue Market Share by Type (2018-2023)
Table 7. Global Mesenchymal Stem Cells Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Mesenchymal Stem Cells Revenue Market Share by Type (2024-2029)
Table 9. Global Mesenchymal Stem Cells Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Mesenchymal Stem Cells Revenue Market Share by Application (2018-2023)
Table 11. Global Mesenchymal Stem Cells Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Mesenchymal Stem Cells Revenue Market Share by Application (2024-2029)
Table 13. Global Mesenchymal Stem Cells Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Mesenchymal Stem Cells Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Mesenchymal Stem Cells Market Share by Region (2018-2023)
Table 16. Global Mesenchymal Stem Cells Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Mesenchymal Stem Cells Market Share by Region (2024-2029)
Table 18. Mesenchymal Stem Cells Market Trends
Table 19. Mesenchymal Stem Cells Market Drivers
Table 20. Mesenchymal Stem Cells Market Challenges
Table 21. Mesenchymal Stem Cells Market Restraints
Table 22. Global Top Mesenchymal Stem Cells Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Mesenchymal Stem Cells Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Mesenchymal Stem Cells Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Mesenchymal Stem Cells, Headquarters and Area Served
Table 26. Global Mesenchymal Stem Cells Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Mesenchymal Stem Cells by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Mesenchymal Stem Cells Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Mesenchymal Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Mesenchymal Stem Cells Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Mesenchymal Stem Cells Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Mesenchymal Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Mesenchymal Stem Cells Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Mesenchymal Stem Cells Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Mesenchymal Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Mesenchymal Stem Cells Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Mesenchymal Stem Cells Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Mesenchymal Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Mesenchymal Stem Cells Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Mesenchymal Stem Cells Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2024-2029) & (US$ Million)
Table 45. Lonza Company Detail
Table 46. Lonza Business Overview
Table 47. Lonza Mesenchymal Stem Cells Product
Table 48. Lonza Revenue in Mesenchymal Stem Cells Business (2017-2022) & (US$ Million)
Table 49. Lonza Recent Development
Table 50. Thermo Fisher Company Detail
Table 51. Thermo Fisher Business Overview
Table 52. Thermo Fisher Mesenchymal Stem Cells Product
Table 53. Thermo Fisher Revenue in Mesenchymal Stem Cells Business (2017-2022) & (US$ Million)
Table 54. Thermo Fisher Recent Development
Table 55. Bio-Techne Company Detail
Table 56. Bio-Techne Business Overview
Table 57. Bio-Techne Mesenchymal Stem Cells Product
Table 58. Bio-Techne Revenue in Mesenchymal Stem Cells Business (2017-2022) & (US$ Million)
Table 59. Bio-Techne Recent Development
Table 60. ATCC Company Detail
Table 61. ATCC Business Overview
Table 62. ATCC Mesenchymal Stem Cells Product
Table 63. ATCC Revenue in Mesenchymal Stem Cells Business (2017-2022) & (US$ Million)
Table 64. ATCC Recent Development
Table 65. MilliporeSigma Company Detail
Table 66. MilliporeSigma Business Overview
Table 67. MilliporeSigma Mesenchymal Stem Cells Product
Table 68. MilliporeSigma Revenue in Mesenchymal Stem Cells Business (2017-2022) & (US$ Million)
Table 69. MilliporeSigma Recent Development
Table 70. PromoCell GmbH Company Detail
Table 71. PromoCell GmbH Business Overview
Table 72. PromoCell GmbH Mesenchymal Stem Cells Product
Table 73. PromoCell GmbH Revenue in Mesenchymal Stem Cells Business (2017-2022) & (US$ Million)
Table 74. PromoCell GmbH Recent Development
Table 75. Genlantis Company Detail
Table 76. Genlantis Business Overview
Table 77. Genlantis Mesenchymal Stem Cells Product
Table 78. Genlantis Revenue in Mesenchymal Stem Cells Business (2017-2022) & (US$ Million)
Table 79. Genlantis Recent Development
Table 80. Celprogen Company Detail
Table 81. Celprogen Business Overview
Table 82. Celprogen Mesenchymal Stem Cells Product
Table 83. Celprogen Revenue in Mesenchymal Stem Cells Business (2017-2022) & (US$ Million)
Table 84. Celprogen Recent Development
Table 85. Cell Applications Company Detail
Table 86. Cell Applications Business Overview
Table 87. Cell Applications Mesenchymal Stem Cells Product
Table 88. Cell Applications Revenue in Mesenchymal Stem Cells Business (2017-2022) & (US$ Million)
Table 89. Cell Applications Recent Development
Table 90. Cyagen Biosciences Company Detail
Table 91. Cyagen Biosciences Business Overview
Table 92. Cyagen Biosciences Mesenchymal Stem Cells Product
Table 93. Cyagen Biosciences Revenue in Mesenchymal Stem Cells Business (2017-2022) & (US$ Million)
Table 94. Cyagen Biosciences Recent Development
Table 95. Axol Bioscience Company Detail
Table 96. Axol Bioscience Business Overview
Table 97. Axol Bioscience Mesenchymal Stem CellsProduct
Table 98. Axol Bioscience Revenue in Mesenchymal Stem Cells Business (2017-2022) & (US$ Million)
Table 99. Axol Bioscience Recent Development
Table 100. Lonza Company Information
Table 101. Lonza Business Overview
Table 102. Lonza Mesenchymal Stem Cells Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million)
Table 103. Lonza Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 104. Lonza Recent Development
Table 105. Thermo Fisher Company Information
Table 106. Thermo Fisher Business Overview
Table 107. Thermo Fisher Mesenchymal Stem Cells Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million)
Table 108. Thermo Fisher Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 109. Thermo Fisher Recent Development
Table 110. Bio-Techne Company Information
Table 111. Bio-Techne Business Overview
Table 112. Bio-Techne Mesenchymal Stem Cells Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million)
Table 113. Bio-Techne Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 114. Bio-Techne Recent Development
Table 115. ATCC Company Information
Table 116. ATCC Business Overview
Table 117. ATCC Mesenchymal Stem Cells Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million)
Table 118. ATCC Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 119. ATCC Recent Development
Table 120. MilliporeSigma Company Information
Table 121. MilliporeSigma Business Overview
Table 122. MilliporeSigma Mesenchymal Stem Cells Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million)
Table 123. MilliporeSigma Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 124. MilliporeSigma Recent Development
Table 125. PromoCell GmbH Company Information
Table 126. PromoCell GmbH Business Overview
Table 127. PromoCell GmbH Mesenchymal Stem Cells Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million)
Table 128. PromoCell GmbH Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 129. PromoCell GmbH Recent Development
Table 130. Genlantis Company Information
Table 131. Genlantis Business Overview
Table 132. Genlantis Mesenchymal Stem Cells Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million)
Table 133. Genlantis Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 134. Genlantis Recent Development
Table 135. Celprogen Company Information
Table 136. Celprogen Business Overview
Table 137. Celprogen Mesenchymal Stem Cells Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million)
Table 138. Celprogen Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 139. Celprogen Recent Development
Table 140. Cell Applications Company Information
Table 141. Cell Applications Business Overview
Table 142. Cell Applications Mesenchymal Stem Cells Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million)
Table 143. Cell Applications Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 144. Cell Applications Recent Development
Table 145. Cyagen Biosciences Company Information
Table 146. Cyagen Biosciences Business Overview
Table 147. Cyagen Biosciences Mesenchymal Stem Cells Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million)
Table 148. Cyagen Biosciences Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 149. Cyagen Biosciences Recent Development
Table 150. Axol Bioscience Company Information
Table 151. Axol Bioscience Business Overview
Table 152. Axol Bioscience Mesenchymal Stem CellsRevenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million)
Table 153. Axol Bioscience Revenue in Mesenchymal Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 154. Axol Bioscience Recent Development
Table 155. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Mesenchymal Stem Cells Product Picture
Figure 5. Global Mesenchymal Stem Cells Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Mesenchymal Stem Cells Market Share by Type: 2022 VS 2029
Figure 7. Human MSC Product Picture
Figure 8. Mouse MSC Product Picture
Figure 9. Rat MSC Product Picture
Figure 10. Others Product Picture
Figure 11. Global Mesenchymal Stem Cells Market Size by Application (2023-2029) & (US$ Million)
Figure 12. Global Mesenchymal Stem Cells Market Share by Application: 2022 VS 2029
Figure 13. Research Institute Product Picture
Figure 14. Hospital Product Picture
Figure 15. Others Product Picture
Figure 16. Global Mesenchymal Stem Cells Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Mesenchymal Stem Cells Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Mesenchymal Stem Cells Market Share by Region: 2022 VS 2029
Figure 19. Global Mesenchymal Stem Cells Market Share by Players in 2022
Figure 20. Global Mesenchymal Stem Cells Players, Date of Enter into This Industry
Figure 21. Global Top 5 and 10 Mesenchymal Stem Cells Players Market Share by Revenue in 2022
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 23. North America Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Mesenchymal Stem Cells Market Share by Country (2018-2029)
Figure 25. United States Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Mesenchymal Stem Cells Market Share by Country (2018-2029)
Figure 29. Germany Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Mesenchymal Stem Cells Market Share by Country (2018-2029)
Figure 37. China Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Mesenchymal Stem Cells Market Share by Country (2018-2029)
Figure 45. Mexico Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Mesenchymal Stem Cells Market Share by Country (2018-2029)
Figure 49. Turkey Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. UAE Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Lonza Revenue Growth Rate in Mesenchymal Stem Cells Business (2018-2023)
Figure 53. Thermo Fisher Revenue Growth Rate in Mesenchymal Stem Cells Business (2018-2023)
Figure 54. Bio-Techne Revenue Growth Rate in Mesenchymal Stem Cells Business (2018-2023)
Figure 55. ATCC Revenue Growth Rate in Mesenchymal Stem Cells Business (2018-2023)
Figure 56. MilliporeSigma Revenue Growth Rate in Mesenchymal Stem Cells Business (2018-2023)
Figure 57. PromoCell GmbH Revenue Growth Rate in Mesenchymal Stem Cells Business (2018-2023)
Figure 58. Genlantis Revenue Growth Rate in Mesenchymal Stem Cells Business (2018-2023)
Figure 59. Celprogen Revenue Growth Rate in Mesenchymal Stem Cells Business (2018-2023)
Figure 60. Cell Applications Revenue Growth Rate in Mesenchymal Stem Cells Business (2018-2023)
Figure 61. Cyagen Biosciences Revenue Growth Rate in Mesenchymal Stem Cells Business (2018-2023)
Figure 62. Axol Bioscience Revenue Growth Rate in Mesenchymal Stem Cells Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Mesenchymal Stem Cells Product Picture
Figure 5. Global Mesenchymal Stem Cells Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Mesenchymal Stem Cells Market Share by Type: 2022 VS 2029
Figure 7. Human MSC Product Picture
Figure 8. Mouse MSC Product Picture
Figure 9. Rat MSC Product Picture
Figure 10. Others Product Picture
Figure 11. Global Mesenchymal Stem Cells Market Size by Application (2023-2029) & (US$ Million)
Figure 12. Global Mesenchymal Stem Cells Market Share by Application: 2022 VS 2029
Figure 13. Research Institute Product Picture
Figure 14. Hospital Product Picture
Figure 15. Others Product Picture
Figure 16. Global Mesenchymal Stem Cells Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Mesenchymal Stem Cells Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Mesenchymal Stem Cells Market Share by Region: 2022 VS 2029
Figure 19. Global Mesenchymal Stem Cells Market Share by Players in 2022
Figure 20. Global Mesenchymal Stem Cells Players, Date of Enter into This Industry
Figure 21. Global Top 5 and 10 Mesenchymal Stem Cells Players Market Share by Revenue in 2022
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 23. North America Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Mesenchymal Stem Cells Market Share by Country (2018-2029)
Figure 25. United States Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Mesenchymal Stem Cells Market Share by Country (2018-2029)
Figure 29. Germany Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Mesenchymal Stem Cells Market Share by Country (2018-2029)
Figure 37. China Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Mesenchymal Stem Cells Market Share by Country (2018-2029)
Figure 45. Mexico Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Mesenchymal Stem Cells Market Share by Country (2018-2029)
Figure 49. Turkey Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. UAE Mesenchymal Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Lonza Revenue Growth Rate in Mesenchymal Stem Cells Business (2018-2023)
Figure 53. Thermo Fisher Revenue Growth Rate in Mesenchymal Stem Cells Business (2018-2023)
Figure 54. Bio-Techne Revenue Growth Rate in Mesenchymal Stem Cells Business (2018-2023)
Figure 55. ATCC Revenue Growth Rate in Mesenchymal Stem Cells Business (2018-2023)
Figure 56. MilliporeSigma Revenue Growth Rate in Mesenchymal Stem Cells Business (2018-2023)
Figure 57. PromoCell GmbH Revenue Growth Rate in Mesenchymal Stem Cells Business (2018-2023)
Figure 58. Genlantis Revenue Growth Rate in Mesenchymal Stem Cells Business (2018-2023)
Figure 59. Celprogen Revenue Growth Rate in Mesenchymal Stem Cells Business (2018-2023)
Figure 60. Cell Applications Revenue Growth Rate in Mesenchymal Stem Cells Business (2018-2023)
Figure 61. Cyagen Biosciences Revenue Growth Rate in Mesenchymal Stem Cells Business (2018-2023)
Figure 62. Axol Bioscience Revenue Growth Rate in Mesenchymal Stem Cells Business (2018-2023)
